Publication | Closed Access
CHROMOGRANIN A CONCENTRATION AS A SERUM MARKER TO PREDICT PROGNOSIS AFTER ENDOCRINE THERAPY FOR PROSTATE CANCER
96
Citations
21
References
2002
Year
Serum chromogranin A tends to be elevated in patients with high grade prostate cancer. When combined with PSA, this marker may effectively predict a poor prognosis after endocrine therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1